Jennifer Sklenar is co-chair of the firm's Intellectual Property practice group and focuses her practice on patent litigation, particularly in the medical device, biotech, semiconductor and networking-related fields. She has managed all aspects of litigation and has significant trial experience in the US District Courts and Section 337 cases in the ITC. She has also been lead counsel in numerous contested Patent Office proceedings.

Experience

  • bioMérieux v. Hologic/Grifols. Served as trial counsel in patent litigation involving HIV-1 amplification technology. Secured a complete jury victory by invalidating the asserted claims on two separate grounds.
  • Hologic v. Minerva. Served as trial counsel in patent litigation involving uterine ablation technology. Obtained summary determination of infringement and no invalidity and secured favorable jury damages verdict.
  • Hologic v. Fujifilm. Served as trial counsel in ITC litigation involving mammography technology. Prevailed in obtaining initial determination and recommended remedies on all issues and in PTAB proceedings.
  • Cytiva v. BioRad. Representing former GE Healthcare subsidiary in pending patent litigation involving liquid chromatography systems.
  • Illumina v. Complete Genomics. Representing family of companies in pending patent litigation involving DNA sequencing technology.
  • Leading Electronics Manufacturer. Serving as counsel in several pending patent litigation matters.
  • Enzo v. Hologic. Served as counsel in several patent litigations involving labeled nucleic acids and target capture technology. Prevailed in obtaining summary adjudication of non-infringement and invalidity, which led to favorable settlement.
  • Waters v. Agilent. Represented Waters in patent litigation involving N-glycan labeling and detection technology. Obtained successful Markman and PTAB determination.
  • Hologic v. IZI. Served as counsel in patent litigation involving mammography technology. Prevailed at trial in obtaining jury verdict of infringement and secured subsequent permanent injunction.
  • Enzo v. Amersham. Served as counsel for GE in patent and contract litigation involving labeled nucleic acids and their detection. Obtained complete summary judgment victory on all claims.

Perspectives

Federal Circuit Holds That Post-Petition Privity and RPI Relationships Are Properly Considered for Purposes of IPR Statutory Time Bar
Advisory
Patent Venue Developments
PLI's Intellectual Property Law Institute 2018, New York and San Francisco
The Freedom to Market - Post Grant Patent Challenges in the US and Europe

Arnold & Porter LLP Webinar

Recognition

Managing Intellectual Property
"IP Star" (California) (2016-2020)
"Top 250 Women in IP" (2017-2020)
PTAB Bar Association
Top 50 Women in PTAB Trials (2019)
Southern California Super Lawyers
Intellectual Property Litigation (2013-2019)
"Rising Star" (2004-2008)

Credentials

Education
  • JD, Hofstra University School of Law, 1994, with distinction
  • BS, Biomedical Engineering, Northwestern University, 1991
Admissions
  • *Admitted in NY and CA only; practice limited to matters before federal courts and federal agencies
  • California
  • New York
  • US District Court, Central District of California
  • US District Court, Northern District of California
  • US District Court, Southern District of California
  • US District Court, Eastern District of New York
  • US District Court, Western District of New York
  • US District Court, Southern District of New York
  • US District Court, Northern District of Texas
  • US Court of Appeals for the Federal Circuit
  • US Patent and Trademark Office
Overview

Email Disclaimer